Intelligence Platform
Patents
Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 10179142
Treatment and/or prevention of bone metastasis
granted patentUS 10174077
Method of inhibiting activity of cell surface fibroblast activation protein alpha
granted patentUS 10172827
Pro-neurogenic compounds
granted patentUS 10172908
Method for treating cognitive dysfunction
granted patentUS 10172976
Muscle cell patches and uses therefor
granted patentUS 10168337
Method and biomarkers for the detection of dengue hemorrhagic fever
granted patentUS 10167337
Combination immunotherapy for the treatment of cancer
granted patentUS 10167259
Allosteric inhibitors of proteasome and methods of use thereof
granted patentUS 10159765
Tissue engineered devices and methods for making same
granted patentUS 10154669
Improving color and release profile of resin compositions comprising silver nanoparticles
granted patentUS 10154881
Methods and compositions for tissue adhesives
granted patentUS 10155003
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes,
granted patentUS 10155789
Substrates and inhibitors of prolyl oligopeptidase and methods of use thereof
granted patentUS 10150753
Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-
granted patentUS 10151756
Predictive markers for polyamine inhibitor cancer therapies
granted patentUS 10149836
Isoxazole treatments for frontotemporal dementia
granted patentUS 10143658
Multistage delivery of active agents
granted patentUS 10144767
Anti-microbial peptides and coatings
granted patentUS 10125128
GLS1 inhibitors for treating disease
granted patentUS 10125167
Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lac
granted patentUS 10125193
Chimeric antigen receptors and methods of making
granted patentUS 10126309
Method for the detection of an albumin isoform
granted patentUS 10125105
Triazabutadienes as cleavable cross-linkers
granted patentUS 10119140
Methods for enhancing or decreasing the levels of MIR124 and MIR29 in subjects with muscul
granted